Strata Skin Sciences has appointed Erica Jordan as chief executive officer, marking a leadership change at the medical technology company. The announcement puts Jordan at the helm of a business focused on device-based treatment options for chronic skin conditions.
Strata Skin Sciences is known for its specialized excimer laser technology. Its XTRAC and Pharos systems are designed to deliver targeted phototherapy with the goal of high efficacy in patients managing long-term dermatology issues.
The company’s product portfolio is associated with treatment support for conditions such as psoriasis and vitiligo. Those disorders often require ongoing care, making specialized laser and phototherapy platforms an important part of Strata’s market position.
With Erica Jordan now named CEO, investors and industry watchers are likely to focus on how Strata Skin Sciences advances its laser technology business and supports adoption of the XTRAC and Pharos systems in chronic skin care.
